PMI’s heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products

Abstract

ImportancePhilip Morris International (PMI) is seeking Food and Drug Administration’s (FDA) authorisation to market IQOS as a modified risk tobacco product and to make marketing claims of reduced risk and reduced exposure. Such claims may be misunderstood by youth, thereby increasing their risk for tobacco initiation.ObjectiveTo assess youth (mean age 19.3, SD=1.7) understanding and perceptions of PMI’s proposed consumer marketing claims of reduced risk and reduced exposure, we embedded a randomised controlled experiment into a survey of 450 California youth (April to August 2018). Participants were randomised to see ‘reduced exposure’, ‘reduced risk’ or neither claim. Perceptions of IQOS-related health risks and general harm and understanding of the term ‘switching completely’ as used in PMI’s proposed claims were compared.ResultsMean expectancies to experience specific health risks did not differ by claim exposure. The reduced exposure group’s perceptions of general harm did not differ from those of controls nor from the reduced risk group. The reduced risk group had the largest proportion who perceived IQOS as moderately/less harmful (n=78, 52%); controls the largest proportion perceiving IQOS as quite/extremely harmful (n=91, 63%). While 71% of the sample understood the term ‘switch completely’ correctly as used in the reduced risk (n=194, 71%) and reduced exposure (n=206, 72%) claims, more than 1 in 4 did not.ConclusionsFDA and other regulators must use caution when considering allowing claims of reduced risk or reduced exposure to appear on retail tobacco packaging. Youth misunderstand such claims, and misperceptions of harm are known to lead to tobacco-use initiation.

Perception of Harmfulness of Various Tobacco Products and E-Cigarettes in Poland: A Nationwide Cross-Sectional Survey

“…We can suspect that the tobacco industry's marketing efforts on the health effect of tobacco use are targeted strictly to smokers to discourage them from quitting smoking. Moreover, a relatively high percentage of respondents (>20%), who declared that e-cigarettes and HTPs are less harmful than traditional cigarettes may result from the fact that these products are aggressively marketed in the EU [28].…”

Smokers’ and Young Adult Non-Smokers’ Perceptions and Perceived Impact of Snus and E-Cigarette Modified Risk Messages

“…This is important given that harm reduction appears to be conditional on completely switching (and not dual product use) [ 11 ]. However, the limited research on this wording so far is somewhat mixed on whether consumers understand what it means [ 12 , 13 , 14 ]. Camel’s proposed ads also include modified exposure claims (e.g., stating that “scientific studies have shown that Camel Snus contains less of the harmful chemicals than cigarette smoke”) as well as several statements attempting to connect the role of combustion with modified risk and exposure (e.g., “no smoke = less risk”).…”

Characterization of Respiratory Symptoms Among Youth Using Heated Tobacco Products in Hong Kong

“…First, due to less harshness than combustible cigarettes and kid-friendly flavors, HTPs can be easier to initiate and more appealing to youth who do not use or lightly use nicotine, and facilitate persistent and frequent use. 39 , 40 , 41 Second, despite no flames, the I Quit Original Smoking (IQOS) tobacco product sticks (Philip Morris International), with similar ingredients to cigarettes, are always charred because of pyrolysis and generate volatile and semi-volatile toxicants as in cigarette smoke, challenging the claim of “heat but not burn.” 4 Third, harmful constituents are increasingly confirmed in HTPs. Many harmful and potentially harmful substances in the aerosol of IQOS are more than 50% higher than cigarette smoke, such as glycerol, α,β-unsaturated carbonyl compounds, 1,2-dicarbonyl compounds, furans and epoxides.…”